Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Enanta Pharmaceuticals, Inc. (ENTA) had Gross Margin of 100.00% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$18.61M |
|
$-11.94M |
|
-- |
|
$18.61M |
|
$29.87M |
|
$-11.25M |
|
$-0.66M |
|
$-11.91M |
|
$-11.91M |
|
$-11.94M |
|
$-11.94M |
|
$-11.94M |
|
$-11.94M |
|
$-11.25M |
|
$-10.00M |
|
28.75M |
|
28.75M |
|
$-0.42 |
|
$-0.42 |
|
| Balance Sheet Financials | |
$198.68M |
|
$34.31M |
|
$130.82M |
|
$329.50M |
|
$44.73M |
|
-- |
|
$158.18M |
|
$202.91M |
|
$126.59M |
|
$126.59M |
|
$126.59M |
|
29.02M |
|
| Cash Flow Statement Financials | |
$-11.70M |
|
$-47.30M |
|
$64.14M |
|
$35.66M |
|
$40.80M |
|
$5.14M |
|
$3.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.44 |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Gross Margin |
100.00% |
-60.45% |
|
-60.45% |
|
-- |
|
-64.00% |
|
-64.13% |
|
$-11.84M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
2.19 |
|
41.06 |
|
-9.43% |
|
-9.43% |
|
-3.62% |
|
-9.43% |
|
$4.36 |
|
$-0.41 |
|
$-0.41 |
|